. . . . . . . "klinisch onderzoek"@nl . . "2014-09-30T00:00:00Z"^^ . . . . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . "NCT02245737" . . . . . . . "An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease"@en . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . "clinical trial"@en . . . . . . . . . "85"^^ . . . . . . . "7255"^^ . . "AMARANTH"@en . . . . . . . . . "An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease"@en . . . . . . . . . . . "A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)"@en . . . . . . "2018-10-04T00:00:00Z"^^ . . . . . . . "An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease"@en . . . "55"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .